June 2018
·
19 Reads
Clinical Hemorheology and Microcirculation
This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.
June 2018
·
19 Reads
Clinical Hemorheology and Microcirculation
December 2016
·
8 Reads
·
6 Citations
Clinical Hemorheology and Microcirculation
The haeraorheological effect of a specific 5-hydroxy-tryptamine antagonist (ketanserin) was studied in 15 patients with severe ischaemic disease, given a continuous infusion for 7 days. The results were compared to a placebo infusion in 10 similar patients. The whole blood viscosity decreased significantly by 11-21% depending on the shear rate applied (0.7, 2.4 and 95 s⁻¹) during active treatment. This viscosity decrease can be attributed to haemodilution, since the blood viscosity data corrected to a standard haematocrit did not show any significant change. The haemodilution may have been partly due to the very marked effect of ketanserin on physical properties of white cells, manifested by a 53% decrease in the number of "clogging particles" in the blood. The red cell deformability index, determined as the transit time of red cells relative to the suspending medium, was also improved by ketanserin.
December 2016
·
4 Reads
Clinical Hemorheology and Microcirculation
December 2016
·
18 Reads
·
6 Citations
Clinical Hemorheology and Microcirculation
December 2016
·
4 Reads
·
3 Citations
Clinical Hemorheology and Microcirculation
August 2015
·
3,192 Reads
·
314 Citations
Journal of Endovascular Therapy
The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) guidelines were last updated in 2007 (TASC II) and represented the collaboration of international vascular specialties involved in the management of patients with peripheral arterial disease (PAD). Since the publication of TASC II, there have been innovations in endovascular revascularization strategies for patients with PAD. The intent of this publication is to provide a complete anatomic lower limb TASC lesion classification, including the infrapopliteal segment, and an updated literature review of new endovascular techniques and practice patterns employed by vascular specialists today. © The Author(s) 2015.
October 2011
·
240 Reads
·
214 Citations
International Journal of Cardiology
October 2011
·
418 Reads
·
2 Citations
Diabetic Medicine
October 2011
·
85 Reads
·
10 Citations
The Lancet
September 2011
·
15 Reads
·
39 Citations
European Journal of Vascular and Endovascular Surgery
A prospective study of 1969 patients with intermittent claudication receiving placebo medication for a minimum of 1 year is reported. Patients were carefully monitored and only four patients were lost to follow-up. Annual mortality was 4.3%. Thirty-six patients developed a definite myocardial infarction, 27 a major stroke, 32 required a major amputation and 111 required surgical or radiological intervention for deteriorating ischaemia of the leg. The entry characteristics of the patients were analysed as a predictor of serious cardiovascular events. The most sensitive predictors of total mortality were age, history of coronary heart disease and an ankle/arm pressure ratio below 0.5. Of the laboratory measurements performed only the initial white cell count was a significant predictor of myocardial infarction, stroke and vascular deaths.
... In approximately 14-20% of patients diagnosed with changes affecting small peripheral arteries, angiographic examination reveals occlusion of arteries without patent distal vessels, which excludes the possibility of reconstructive treatment [34,35]. Venous arterialization is an option to improve the local condition and reduce ischemia in patients with diseases affecting the distal part of the arterial tree, in whom pharmacological therapy does not bring the intended effects [36]. ...
January 1999
BJS (British Journal of Surgery)
... Although there are recommendations of International Committee for Measurements of Blood Viscosity (ICSH, 1986), the interpretation and comparison of clinical whole blood viscosity data are not satisfactory. This is because workers in this field generally, while reporting viscosity values have used one or two different particular shear rates (Walker et al 1985; Lechner et al 1986; Ott et al 1986; Caimi et al 1987; Ernst et al 1987; Fisher et al 1987). There has been no agreement about the shear rates at which the viscosity should be compared between two given samples (Inglis et al 1981). ...
December 2016
Clinical Hemorheology and Microcirculation
... Arteriosclerosis obliterans of the lower limbs is caused by the formation of atherosclerotic plaques of the lower limbs, which leads to arterial stenosis and occlusion, leading to chronic limb ischemia. Percutaneous superficial femoral interventions are the preferred treatment for superficial femoral artery disease, even though the occurrence of in-stent restenosis (ISR) continues to be an important complication [1][2]. The mechanism of stent restenosis is unclear. ...
January 2007
... Approximately 50% of women and 20% of men report discomfort associated with varicose veins [5]. It is estimated that the annual cost of treating varicose veins in Western countries may exceed 2% of the total healthcare budget [6,7]. ...
January 1999
... Despite various attempts to improve the overall mobility and independence of the lower limb amputee, the result has been rather depressing (Dormandy and Ray, 1995; Collin and Collin, 1995). The majority of amputees belong to the dysvascular group and are aged. ...
November 1994
Vascular Medicine Review
... Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) parameters, their definitions, and their interpretations. This table also depicts the different ROTEM assays, their activators, and the differences among them[109][110][111][112][113]. ...
January 2001
... Dilatation and incompetence of the great saphenous vein leads to increased ambulatory venous pressure, microvascular ischaemia and cutaneous tissue breakdown. 1 Several factors affect tissue viability and susceptibility to ulceration, but the structural and functional integrity of the microcirculation to maintain blood flow, tissue oxygenation and nutrient delivery despite changes in systemic and local haemodynamics may be especially important. 2 For example, we have previously shown that cutaneous microvascular vasodilator responses in the perimalleolar region are impaired in the upright position in patients with isolated great saphenous vein incompetence compared with healthy controls. ...
February 1993
Vascular Medicine Review
... One possible consideration for the observed frequency differences could be variations in the definition of restenosis or loss of clinical patency, as well as differences in the inclusion criteria. Although there are lingering concerns regarding the safety and efficacy of the SI approach for CTO lesions of the FP region 19 , the outcomes of SI have been enhanced through numerous advancements in techniques and devices 5,22 . Therefore, to date, there is no evidence favoring either the IL or SI route in terms of midterm results for BMS or drug-eluting devices 5,19 . ...
August 2015
Journal of Endovascular Therapy
... 17 Unfortunately, studies that permit its benefit to be quantified are not available, especially among the subgroup of patients with an acutely thrombosed PAA. 18,19 Therefore, the aim of this study was to investigate outcomes of intra-operative intra-arterial thrombolysis with tissue plasminogen activator (tPA) as a thrombolytic agent in the treatment of acute PAA thrombosis Rutherford grade IIa and IIb in terms of major adverse limb events (MALE), overall survival, and intrahospital complications, especially those associated with bleeding. ...
January 1998
The American Journal of Cardiology
... These results argue against a putative role for pioglitazone in development of bladder cancer. Further, overall incidence of malignancy has been reported not to increase (106) or decrease in certain cancer types (breast and liver) in pioglitazone-treated patients (188,(190)(191)(192). Lastly, any increased bladder cancer risk must be viewed in the context of protection against all-cause death, MI, and stroke, i.e., MACE end point in PROactive. ...
March 2006
The Lancet